Pharmaceutics - Medika Life

The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

BIO – Biotech Without Borders

Is Getting COVID Shots in the Same Arm Better?

It’s Time to Up Our Messaging Game Ahead of Another Winter with COVID

New Alzheimer’s Drugs Will Worsen Inequality

LATEST

TRENDING

The Evolution of Quinine to Hydroxychloroquine, Covid’s Snake Oil

Ten mRNA Facts You Probably Didn’t Know About and Ten Nonsenses

Adrenochrome, Satanic Masses, Abducted Children and Urban Legends

Ten Facts You Didn’t Know About Moderna and Their mRNA Vaccine

Killing The Coronavirus. A New Treatment Shows 99.9 Percent Efficacy

Phexxi; Have You Heard About This New Hormone-Free Contraceptive?

Ivermectin is NOT Hydroxychloroquine. Why is the FDA Ignoring a Potential Covid Treatment?

Kratom is an Unregulated Addictive Drug That Kills

Healthcare Workers Show Their Faith in the Covid Vaccine #vaccinechallenge

Gain of Function Research. Have We Opened Pandora’s Box?

EDITORS CHOICE

Krispy Kreme Offers Free Doughnuts to Promote Covid-19 Vaccinations

Busted! Explaining Common Vaccine Myths

How to Wee Away your UTI. New Research from Rutgers

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories